«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:

期数:

2025年03期

页码:

390-394

栏目:

论著

出版日期:

2025-06-25

文章信息/Info

Title:

Correlation between cognitive decline and the degree of sleep apnea in patients with chronic obstructive pulmonary disease

作者:

王 丹¹; 王昌锋¹; 王 丽²; 綦 彬²; 叶媛媛¹; 范 浩²

438000 黄冈,黄冈市中心医院呼吸与危重症医学科¹
438000 黄冈,黄冈市中心医院耳鼻咽喉头颈外科²

Author(s):

Wang Dan¹;  Wang Changfeng²;  Wang Li²;  Qi Bin²;  Ye Yuanyuan¹;  Fan Hao².

¹Department of Respiratory and Critical Care Medicine, Huanggang Central Hospital, Huanggang 438000, China; ²Department of Otorhinolaryngology Head and Neck Surgery, Huanggang Central Hospital, Huanggang 438000, China

关键词:

肺疾病; 慢性阻塞性;  睡眠呼吸暂停;  认知功能;  临床分析

Keywords:

Chronic obstructive pulmonary disease;  Sleep apnea;  Cognitive function;  Clinical nanlysis

分类号:

R563

DOI:

10.3877/cma.j.issn.1674-6902.2025.03.009

摘要:

目的 分析睡眠呼吸暂停(obstructive sleep apnea, OSA)程度与慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)患者认知功能减退的临床意义。方法 选取2022年1月至2024年8月我院收治的COPD患者118例为对象,根据呼吸暂停低通气指数(apnea hypopnea index, AHI)分为对照组38例(AHI<5次/h)、轻度组38例(5次/h≤AHI <15次/h)、中度组30例(15次/h≤AHI<30次/h)和重度组12例(AHI≥30次/h)。比较每组患者临床资料、肺功能及认知功能。采用Pearson相关性分析和多元线性回归分析睡眠呼吸暂停程度与COPD患者认知功能的相关性。结果 每组第一秒用力呼气容积/用力肺活量(forced expiratory volume in the first second / forced vital capacity, FEV₁/FVC)、第一秒用力呼气容积占预计值百分比(forced expiratory volume in the first second as a percentage of predicted value, FEV₁%Pred)差异有统计学意义,对照组、轻度组、中度组及重度组FEV₁/FVC分别为(61.25±4.09)%、(58.64±5.17)%、(52.65±6.22)%、(48.97±4.19)%,FEV₁%Pred分别为(75.33±2.75)%、(72.61±4.86)%、(62.64±5.44)%、(58.67±4.59)%; 重度组FEV₁/FVC、FEV₁%Pred低于对照组、轻度组和中度组(P<0.05)。每组视空间/执行功能、注意力、记忆力及蒙特利尔认知评估量表(montreal cognitive assessment scale, MoCA)总评分差异有统计学意义(P<0.05),重度组视空间/执行功能、注意力、记忆力及MoCA评分分别为(3.31±0.67)分、(4.66±0.15)分、(3.52±0.29)分、(24.18±2.01)分,对照组分别为(4.58±0.12)分、(5.61±0.27)分、(4.39±0.24)分、(28.33±1.17)分(P<0.05); Pearson相关性分析显示,AHI与MoCA呈负相关(r=-0.616,P=0.001)。多元逐步回归分析显示,AHI可负向影响COPD患者认知功能(P<0.05)。118例OSA与CODP患者认知功能减退经救治后生存者98例(83.05%),救治疗效不佳死亡者20例(16.95%)。结论 OSA程度与COPD患者认知功能减退风险有关,判断COPD患者OSA病情,早期识别及救治OSA,有助于降低认知功能减退风险。

Abstract:

Objective To analyze the clinical analysis between the severity of sleep apnea and the risk of cognitive decline in patients with chronic obstructive pulmonary disease(COPD). Methods A total of 118 COPD patients admitted to our hospital from January 2022 to August 2024 were enrolled. They were divided into four groups based on the apnea hypopnea index(AHI): control group 38 cases(AHI<5 events/h), mild group 38 cases(5 events/h≤ AHI<15 events/h), moderate group 30 cases(15 events/h≤AHI<30 events/h), and severe group12 cases( AHI≥30 events/h). General data, pulmonary function, and cognitive function were compared among the groups. Pearson correlation analysis and multiple linear regression were used to assess the correlation between sleep apnea severity and cognitive function in COPD patients. Results Significant differences were observed among the groups in forced expiratory volume in the first second/forced vital capacity(FEV₁/FVC)and forced expiratory volume in the first second as a percentage of predicted value(FEV₁%Pred). The FEV₁/FVC values for the control, mild, moderate, and severe groups were(61.25±4.09)%,(58.64±5.17)%,(52.65±6.22)%, and(48.97±4.19)%, respectively. FEV₁%Pred values were(75.33±2.75)%,(72.61±4.86)%,(62.64±5.44)%, and(58.67±4.59)%, respectively. The severe group had significantly lower FEV₁/FVC and FEV₁%Pred compared to the control, mild, and moderate groups(P<0.05). Significant differences were also observed in visuospatial/executive function, attention, memory, and total Montreal Cognitive Assessment Scale(MoCA)scores among the groups(P<0.05). The severe group scored(3.31±0.67),(4.66±0.15),(3.52±0.29), and(24.18±2.01)in these domains, respectively, while the control group scored(4.58±0.12),(5.61±0.27),(4.39±0.24), and(28.33±1.17)(P<0.05). Pearson correlation analysis revealed a negative correlation between AHI and MoCA scores(r=-0.616, P=0.001). Multiple stepwise regression analysis indicated that AHI negatively impacted cognitive function in COPD patients(P<0.05). Among 118 patients with OSA and CODP who had cognitive decline, 98(83.05%)survived after treatment, and 20(16.95%)died due to poor treatment efficacy.Conclusion The severity of sleep apnea is associated with the risk of cognitive decline in COPD patients. Assessing sleep apnea in COPD patients and implementing early interventions may help reduce the risk of cognitive impairment.

参考文献/References:

1 卢俊伟, 于晓童, 陈 碧. 慢性阻塞性肺疾病伴睡眠障碍的研究进展[J]. 中国当代医药, 2024, 31(18): 190-194.
2 盛梅梅, 罗专波. 慢性阻塞性肺疾病发病机制的研究现状及进展[J/CD]. 现代医学与健康研究(电子版), 2023, 7(1): 38-41.
3 Qian Y, Cai C, Sun M, et al. Analyses of factors associated with acute exacerbations of chronic obstructive pulmonary disease: A review[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 2707-2723.
4 Read N, Jennings C, Hare A. Obstructive sleep apnoea-hypopnoea syndrome[J]. Emerg Top Life Sci, 2023, 7(5): 467-476.
5 Thomas E, Micic G, Adams R, et al. Pharmacological management of co-morbid obstructive sleep apnoea and insomnia[J]. Expert Opin Pharmacother, 2023, 24(18): 1963-1973.
6 Ioachimescu OC, McNicholas WT. Chronic obstructive pulmonary disease-obstructive sleep apnea overlap: More than a casual acquaintance[J]. Am J Respir Crit Care Med, 2022, 206(2): 139-141.
7 Locke BW, Lee JJ, Sundar KM. OSA and chronic respiratory disease:Mechanisms and epidemiology[J]. Int J Environ Res Public Health, 2022, 19(9): 5473.
8 Lurie A, Roche N. Obstructive sleep apnea in patients with chronic obstructive pulmonary disease: Facts and perspectives[J]. COPD, 2021,18(6): 700-712.
9 陈 杨, 李 茜, 杨中华. 慢性阻塞性肺疾病急性加重期合并VTE抗凝治疗的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2024, 17(2): 316-319.
10 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 成人阻塞性睡眠呼吸暂停基层诊疗指南(2018年)[J]. 中华全科医师杂志, 2019, 18(1): 21-29.
11 张立秀, 刘雪琴. 蒙特利尔认知评估量表中文版的信效度研究[J]. 护理研究, 2007,21(31):2906-2907.
12 洪亚男, 丁 震, 裴 翀, 等. 中-重度阻塞性睡眠呼吸暂停对认知功能及焦虑和抑郁影响的分析[J]. 心肺血管病杂志, 2024, 43(3): 274-280.
13 Lin S, Lin X, Chen S, et al. Association of MRI indexes of the perivascular space network and cognitive impairment in patients with obstructive sleep apnea[J]. Radiology, 2024, 311(3): e232274.
14 Raphelson JR, Sanchez-Azofra A, Malhotra A. Sleep apnea and chronic obstructive pulmonary disease overlap: More common than you think?[J]. Am J Respir Crit Care Med, 2023, 208(4): 505-506.
15 Henrot P, Dupin I, Schilfarth P, et al. Main pathogenic mechanisms and recent advances in COPD peripheral skeletal muscle wasting[J]. Int J Mol Sci, 2023, 24(7): 6454.
16 Marin-Oto M, Sanz-Rubio D, Santamaria-Martos F, et al. Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea[J]. Respir Res, 2022, 23(1): 163.
17 Kang J, Park HK, Koo HK, et al. Estimating the prevalence and clinical significance of chronic obstructive pulmonary disease-obstructive sleep apnea overlap in South Korea[J]. Sleep Med, 2024, 114: 237-243.
18 Siraj RA. Comorbid cognitive impairment in chronic obstructive pulmonary disease(COPD): Current understanding, risk factors, implications for clinical practice, and suggested interventions[J]. Medicina(Kaunas), 2023, 59(4): 732.
19 Richie RC. Assessing the pathophysiology, morbidity, and mortality of obstructive sleep apnea[J]. J Insur Med, 2024, 51(3): 143-162.
20 Bae E, Kwak N, Choi SM, et al. Mortality prediction in chronic obstructive pulmonary disease and obstructive sleep apnea[J]. Sleep Med, 2021, 87: 143-150.
21 Hansen KK, Lokke A, Jensen HI, et al. Examining the impact of obstructive sleep apnea on cognitive function in severe COPD[J]. Sleep Breath, 2024, 29(1): 59.
22 Zhu Z, Wu Y, Qu L, et al. Evaluation of nocturnal apnea and airflow limitation as indicators for cognitive dysfunction in patients with chronic obstructive pulmonary disease/obstructive sleep apnea hypopnea syndrome overlap syndrome[J]. Chron Respir Dis, 2024, 21: 211306484.
23 Zhang XL, Gao B, Han T, et al. Moderate-to-severe obstructive sleep apnea and cognitive function impairment in patients with COPD[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15: 1813-1822.
24 平彤彤, 张艳平, 高 敏, 等. OSAHS患者NGB、AOPP及多导睡眠监测指标与认知损伤关系[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(3): 409-411.
25 林 静, 陈 芳, 刘小霞. COPD患者认知功能障碍影响因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(4): 569-571.
26 Khanduja S, Kim J, Kang JK, et al. Hypoxic-Ischemic Brain Injury in ECMO: Pathophysiology, Neuromonitoring, and Therapeutic Opportunities[J]. Cells, 2023, 12(11): 1546.
27 Valable S, Toutain J, Divoux D, et al. Magnetic resonance imaging of hypoxia in acute stroke compared with fluorine-18 fluoromisonidazole-positron emission tomography: A cross-validation study?[J]. NMR Biomed, 2023, 36(3): e4858.
28 Lv Z, Chen Q, Jiang Y, et al. Abnormal static and dynamic local-neural activity in COPD and its relationship with pulmonary function and cognitive impairments[J]. Front Hum Neurosci, 2020, 14: 580238.
29 Xu C, Xia J, Qiang Y, et al. Relationship between burden of cerebral small vessel disease on imaging and cognitive impairment of COPD patients[J]. J Neurosci Methods, 2024, 410: 110218.
30 Zhou L, Yang H, Zhang Y, et al. Association of impaired lung function with dementia, and brain magnetic resonance imaging indices: a large population-based longitudinal study[J]. Age Ageing, 2022, 51(11): 269.

备注/Memo

备注/Memo:

通信作者: 范 浩, Email: 77847045@qq.com

常用功能

更新日期/Last Update: 2025-06-25